Cargando…

Soluble CD59 is a Novel Biomarker for the Prediction of Obstructive Chronic Lung Allograft Dysfunction After Lung Transplantation

CD59 is a complement regulatory protein that inhibits membrane attack complex formation. A soluble form of CD59 (sCD59) is present in various body fluids and is associated with cellular damage after acute myocardial infarction. Lung transplantation (LTx) is the final treatment for end-stage lung dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Budding, Kevin, van de Graaf, Eduard. A., Kardol-Hoefnagel, Tineke, Kwakkel-van Erp, Johanna M., Luijk, Bart D., Oudijk, Erik-Jan D., van Kessel, Diana A., Grutters, Jan C., Hack, C. Erik, Otten, Henderikus G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877647/ https://www.ncbi.nlm.nih.gov/pubmed/27215188 http://dx.doi.org/10.1038/srep26274

Ejemplares similares

Association between a Single Donor TARC/CCL17 Promotor Polymorphism and Obstructive Chronic Lung Allograft Dysfunction after Lung Transplantation
por: Budding, Kevin, et al.
Publicado: (2017)

Antibodies against Apoptotic Cells Present in End-stage Lung Disease Patients Do Not Correlate with Clinical Outcome after Lung Transplantation
por: Budding, Kevin, et al.
Publicado: (2017)

The Autoimmune-Associated Single Nucleotide Polymorphism Within PTPN22 Correlates With Clinical Outcome After Lung Transplantation
por: Budding, Kevin, et al.
Publicado: (2019)

A Single Nucleotide C3 Polymorphism Associates With Clinical Outcome After Lung Transplantation
por: Kardol-Hoefnagel, Tineke, et al.
Publicado: (2019)

Reduced Expression of Membrane Complement Regulatory Protein CD59 on Leukocytes following Lung Transplantation
por: Michielsen, Laura A., et al.
Publicado: (2018)

Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant Outcome
por: Michielsen, Laura A., et al.
Publicado: (2018)

Effective Prolonged Therapy with Voriconazole in a Lung Transplant Recipient with Spondylodiscitis Induced by Scedosporium apiospermum
por: Luijk, B., et al.
Publicado: (2011)

Complement component C3 and C5b‐9 deposition on hypoxia reperfused endothelial cells by non‐HLA antibodies against RhoGDI2: A player involved in graft failure?
por: Kardol‐Hoefnagel, Tineke, et al.
Publicado: (2022)

The Induction of IgM and IgG Antibodies against HLA or MICA after Lung Transplantation
por: Paantjens, Annelieke W. M., et al.
Publicado: (2011)

A Comprehensive Overview of the Clinical Relevance and Treatment Options for Antibody-mediated Rejection Associated With Non-HLA Antibodies
por: Kardol-Hoefnagel, Tineke, et al.
Publicado: (2020)

A Review on the Function and Regulation of ARHGDIB/RhoGDI2 Expression Including the Hypothetical Role of ARHGDIB/RhoGDI2 Autoantibodies in Kidney Transplantation
por: Kardol-Hoefnagel, Tineke, et al.
Publicado: (2020)

Accuracy of CT Pulmonary Artery Diameter for Pulmonary Hypertension in End-Stage COPD
por: Mohamed Hoesein, Firdaus A., et al.
Publicado: (2016)

A genetic polymorphism in the CAV1 gene associates with the development of bronchiolitis obliterans syndrome after lung transplantation
por: Kastelijn, Elisabeth A, et al.
Publicado: (2011)

Biomarkers for Chronic Lung Allograft Dysfunction: Ready for Prime Time?
por: Verleden, Stijn E., et al.
Publicado: (2022)

The relation between psychological distress and medication adherence in lung transplant candidates and recipients: A cross‐sectional study
por: Wessels‐Bakker, Marion J., et al.
Publicado: (2021)

Comparison of Two Strategies to Generate Antigen-Specific Human Monoclonal Antibodies: Which Method to Choose for Which Purpose?
por: Ehlers, Anna M., et al.
Publicado: (2021)

Waiting List Dynamics and Lung Transplantation Outcomes After Introduction of the Lung Allocation Score in The Netherlands
por: Hoffman, Thijs W., et al.
Publicado: (2021)

Impact of donor lung quality on post‐transplant recipient outcome in the Lung Allocation Score era in Eurotransplant – a historical prospective study
por: Smits, Jacqueline M., et al.
Publicado: (2020)

Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
por: Hoffman, Thijs W., et al.
Publicado: (2020)

Clustering of lung diseases in the family of interstitial lung disease patients
por: Terwiel, Michelle, et al.
Publicado: (2022)

Pretransplant HRCT Characteristics Are Associated with Worse Outcome of Lung Transplantation for Cystic Fibrosis Patients
por: Belle-van Meerkerk, Gerdien, et al.
Publicado: (2015)

Multidisciplinary diagnosis of interstitial lung disease in Zambia using videoconferencing
por: Hoffman, Thijs, et al.
Publicado: (2022)

Clinical similarities among bradykinin-mediated and mast cell-mediated subtypes of non-hereditary angioedema: a retrospective study
por: Schulkes, Karlijn J G, et al.
Publicado: (2015)

Emphysema Is Common in Lungs of Cystic Fibrosis Lung Transplantation Patients: A Histopathological and Computed Tomography Study
por: Mets, Onno M., et al.
Publicado: (2015)

Oesophageal stasis is a risk factor for chronic lung allograft dysfunction and allograft failure in lung transplant recipients
por: Ramendra, Rayoun, et al.
Publicado: (2023)

Decreased Survival and Lung Function in Progressive Pulmonary Fibrosis
por: Platenburg, Mark G. J. P., et al.
Publicado: (2023)

Lung retransplantation for chronic lung allograft dysfunction
por: Kosiorowska, Monika, et al.
Publicado: (2019)

Radiation-induced cardiac side-effects: The lung as target for interacting damage and intervention
por: Wiedemann, Julia, et al.
Publicado: (2022)

Radiologic and histologic correlates of early interstitial lung changes in explant lungs
por: Verleden, Stijn E., et al.
Publicado: (2023)

Aspergillus-Specific IgG Antibodies are Associated With Fungal-Related Complications and Chronic Lung Allograft Dysfunction After Lung Transplantation
por: Beeckmans, Hanne, et al.
Publicado: (2023)

Patient‐reported health outcomes in long‐term lung transplantation survivors: A prospective cohort study
por: Shahabeddin Parizi, A., et al.
Publicado: (2017)

Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane
por: Willemsen, Annelieke E. C. A. B., et al.
Publicado: (2019)

Understanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed Lungs
por: van Moorsel, Coline H. M., et al.
Publicado: (2015)

The effect of COVID-19 on transplant function and development of CLAD in lung transplant patients: A multicenter experience
por: Roosma, Elizabeth, et al.
Publicado: (2022)

DDX59 promotes DNA replication in lung adenocarcinoma
por: You, Jin, et al.
Publicado: (2017)

Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation
por: Suwara, Monika I, et al.
Publicado: (2014)

The Role of Galectins in Chronic Lung Allograft Dysfunction
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Use of High Dose Corticosteroids Reversed COVID-19 Associated ARDS in a Patient Listed for Lung Transplantation
por: Verplancke, V., et al.
Publicado: (2022)

Lung Allograft Microbiome Association with Gastroesophageal Reflux, Inflammation, and Allograft Dysfunction
por: Schneeberger, Pierre H. H., et al.
Publicado: (2022)

ALEMTUZUMAB FOR CHRONIC LUNG ALLOGRAFT DYSFUNCTION
por: Girgis, Reda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8rala4va9ncujv6k8er9rfrj4b